The upper sphincter, at the bottom of the throat
R-CPD
Retrograde cricopharyngeus dysfunction
Also called inability to burp, abelchia, no-burp syndrome.
- What fails
- Will not open to let air come back up
- Test to ask for
- Diagnosed from symptoms by a laryngologist; sometimes manometry with a fizzy drink
- Who to ask
- Ear, nose and throat doctor (laryngologist)
- Who gets it
- Usually starts in childhood
What do the test names and numbers mean?
- Manometry
- A thin tube measures pressure as you swallow.
- Endoscopy
- A small camera examines the food pipe.
- Videofluoroscopy
- A moving X-ray taken while you swallow.
- 95% confidence interval (CI)
- A statistical range showing uncertainty around a study estimate. It is not a promise about an individual person.
- Median and IQR
- The median is the middle value. The interquartile range (IQR) contains the middle half of the results.
- Odds ratio
- A comparison of odds between two groups. It is not the same as a difference in percentage points.
What it is
At the bottom of your throat, just behind the lower edge of the voice box, there is a ring of muscle called the cricopharyngeus. It is the upper sphincter of the esophagus. It stays squeezed shut almost all the time and opens for about a second each time you swallow1. It is also meant to open the other way for a moment, when air rises out of the stomach and needs to leave as a burp.
In R-CPD that second job fails. The muscle opens normally for swallowing but will not relax to let air back out, so the air stays trapped below it2,3. The esophagus then pushes the air back down. That is thought to be where the gurgling, the bloating and the extra gas come from, although the exact mechanism has not been proven3.
It was first described, in a single patient, in 19874,5, and then named and given a treatment in 2019 by Robert Bastian, a laryngologist2.
What it feels like
People with R-CPD often report being unable to burp for as long as they can remember. In the first group of 51 patients, 50 said they had been unable to burp for as long as they could remember2.
After eating or drinking, especially anything fizzy, there is pressure in your chest or upper belly that a burp would fix, and the burp does not come. Instead there are noises: gurgling, croaking or squeaking from the bottom of the neck and the chest. Patients in that first study compared them to frogs and dinosaurs2. Your stomach swells as the day goes on, and the gas leaves the other way, often through the evening and into the night6.
Many people also find it hard or impossible to throw up7, and in one survey 80% reported painful hiccups8. It usually starts in childhood3. In a survey of 199 people from the r/noburp community, the typical answer was that the symptoms caused real embarrassment and anxiety, and 90% disagreed that they had received adequate help7.
What tells it apart from the ones next to it
From A-CPD. Same muscle, opposite direction. In A-CPD the sphincter does not open well for food going down, so pills and solid food catch at the bottom of the throat. In R-CPD swallowing is normal. Only air coming up is blocked1,9. The ages are different too. R-CPD usually begins in childhood and gets diagnosed in the late twenties or thirties3,10. A-CPD is mostly found in older adults. In a study of 250 people with a tight cricopharyngeus, most of whom also had a Zenker's pouch, the mean age was 6911.
From reflux. Heartburn and acid can come with R-CPD as well. Across studies, reflux disease was found in somewhere between 16 and 52 percent of people with R-CPD12. That overlap is part of why it gets missed: about a third of people in a 2026 survey said a doctor had put their symptoms down to reflux8.
From achalasia. People with achalasia often have trouble belching too, up to 85% in older reports13. But achalasia makes food and drink stick in the chest and come back up undigested, and it usually begins in adulthood14. R-CPD on its own does not make food stick.
How it gets confirmed
Mostly from the story of your symptoms. In a review of 17 studies, most diagnosed R-CPD from symptoms alone, and only 3 groups also used manometry3. A survey of US laryngologists found that they mainly treat it as a clinical diagnosis15.
Bastian's approach is to diagnose from the pattern of symptoms and let the treatment act as the test: improvement after a clinician-administered injection can support the diagnosis alongside a medical assessment2.
Tests do exist. High-resolution impedance manometry while you drink something fizzy can show the sphincter staying shut as gas rises5,16. Endoscopy and swallow studies are used mainly to rule other things out, and in one pooled review none of them explained the symptoms17.
The person to ask for is an ear, nose and throat doctor, ideally a laryngologist, who treats R-CPD. The community-run site noburp.info keeps a directory of clinicians18.
How it gets treated
The standard treatment is Botox (botulinum toxin) injected into the cricopharyngeus. It weakens the muscle for a few months so that air can get out2.
- Under general anesthesia. Bastian's original method. A short anesthetic, a rigid scope through the mouth, and usually 50 units injected at several points in the muscle2.
- Awake, in clinic. Through the skin of the neck, guided by electromyography (EMG), which records the muscle’s electrical activity10,19.
- Under sedation. Through a flexible endoscope passed down the throat20.
Starting doses in published studies ranged from 10 to 100 units, and 50 was the most common17. Many people keep the ability to burp after the drug has worn off. In a series of 200 patients, 79.9% of those who were helped could still burp six months or more after a single injection21. If symptoms return, the injection can be repeated. A small number of people have a myotomy instead, which cuts the muscle, usually with a laser through the mouth1,17.
What the evidence says
- It works quickly for most people. Pooled across 13 case series with 699 patients, 91% had relief within one to four weeks (95% CI 84 to 96)22. The 2025 systematic review reports 92.5% immediate success3.
- For most, it lasts. Across studies with mean follow-up periods ranging from 3 to 29 months, sustained relief was 80% (95% CI 71 to 87)22. In the review, symptoms came back in 9.5% of patients in the first month, 12.6% between one and five months, and 27.9% after six months3.
- The usual side effect is temporary trouble swallowing. 31.1% in the systematic review3 and 51% in the meta-analysis (95% CI 38 to 64)22. In one clinic series it lasted 16 days on average10.
- Most people find the name themselves. In the 5 studies that recorded how the diagnosis was made, patients had recognised it themselves in 78.9% of cases3. In a French series of 106 patients, 99.1% had worked it out themselves after a combined 162 medical visits. Their symptoms started at a mean age of 13.6 and they were diagnosed at a mean age of 30.410.
- How sure we can be. There are no randomized trials. Apart from one small study with an untreated comparison group, every study is a case series or a survey, and the review authors judged all of them at risk of bias3. In that comparison study, 92% of treated patients could burp at three months, against none of 7 untreated controls20.
Studies to ask about
Get email alerts about new potential studies
Our ClinicalTrials.gov search found no studies listed as recruiting or not yet recruiting for R-CPD on 8 October 2026. Other studies may exist. See the trials for the other four conditions.
Often confused with
Sources
Every number on this page comes from one of these. Numbers in the text link here.
- Bastian RW. Retrograde cricopharyngeus dysfunction (R-CPD). Laryngopedia, Bastian Voice Institute.
- Bastian RW, Smithson ML. Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment. OTO Open. 2019. PMID 31236539
- Lechien JR, Mailly M, Hans S et al.. Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review. J Otolaryngol Head Neck Surg. 2025. PMID 40411338
- Kahrilas PJ, Dodds WJ, Hogan WJ. Dysfunction of the belch reflex. A cause of incapacitating chest pain. Gastroenterology. 1987. PMID 3623025
- Lehmann A, Kahrilas PJ. Retrograde cricopharyngeus dysfunction (R-CPD), also known as inability to belch syndrome-a narrative review. Transl Gastroenterol Hepatol. 2026. PMID 42291160
- Bastian RW. Can't burp? Here are the symptoms of R-CPD. Laryngopedia, Bastian Voice Institute.
- Chen JN, Evans J, Fakhreddine AB et al.. Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?. Neurogastroenterol Motil. 2024. PMID 38115814
- Chen JN, Swain C, Appiah D et al.. Early-Life and Psychosocial Factors in Adults with Symptoms Consistent with Retrograde Cricopharyngeus Dysfunction. J Clin Med. 2026. PMID 41977029
- Bastian RW. Antegrade cricopharyngeal dysfunction (A-CPD). Laryngopedia, Bastian Voice Institute.
- Mailly M, Baudouin R, Thibault C et al.. Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction. JAMA Otolaryngol Head Neck Surg. 2025. PMID 39883449
- Howell RJ, Ekbom D, Kasperbauer J et al.. Cricopharyngeus Muscle Dysfunction and Hypopharyngeal Diverticula (e.g., Zenker): A Multicenter Study. Laryngoscope. 2023. PMID 36102298
- Mailly M, Lechien JR. Retrograde Cricopharyngeal Dysfunction: An Update of Pathophysiological Mechanisms and Future Directions. Toxins (Basel). 2025. PMID 41591155
- Patel DA, Kim HP, Zifodya JS et al.. Idiopathic (primary) achalasia: a review. Orphanet J Rare Dis. 2015. PMID 26198208
- Vaezi MF, Pandolfino JE, Yadlapati RH et al.. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. Am J Gastroenterol. 2020. PMID 32773454
- Razura DE, Ulloa R, Lin ME et al.. A National Survey on Retrograde Cricopharyngeus Dysfunction Practice Patterns Among Laryngologists. Laryngoscope. 2025. PMID 40095711
- Raymenants K, Vulsteke F, Vanuytsel T et al.. Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects. Clin Gastroenterol Hepatol. 2026. PMID 39892633
- Malhotra R, Khan H, Zaransky S et al.. Diagnosis and Management of Retrograde Cricopharyngeal Dysfunction: A Systematic Review. OTO Open. 2024. PMID 39411246
- noburp.info. R-CPD information, self check and clinician directory. noburp.info.
- Wajsberg B, Hoesli RC, Wingo ML et al.. Efficacy and Safety of Electromyography-Guided Injection of Botulinum Toxin to Treat Retrograde Cricopharyngeus Dysfunction. OTO Open. 2021. PMID 33598599
- Sanagapalli S, Eid M, Kim MB et al.. Prospective Controlled Study of Endoscopic Botulinum Toxin Injection for Retrograde Cricopharyngeus Dysfunction: The Inability to Belch Syndrome. Am J Gastroenterol. 2025. PMID 39589004
- Hoesli RC, Wingo ML, Bastian RW. The Long-term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction. OTO Open. 2020. PMID 32647778
- Yeo WX, Tan BKJ, Gao EY et al.. Botulinum Toxin Injection in Retrograde Cricopharyngeal Dysfunction: A Meta-Analysis. Laryngoscope. 2025. PMID 40481760